Koshinski Asset Management
VTGN icon

Koshinski Asset Management’s VistaGen Therapeutics VTGN Stock Holding History

Koshinski Asset Management’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-120
Closed -$9.86K – 2253
2021
Q3 		$9.86K Buy
+120
New +$10.4K ﹤0.01% 1661
2021
Q1 		– Sell
-760
Closed -$44K – 642
2020
Q4 		$44K Buy
760
+93
+14% +$2.37K 0.01% 540
2020
Q3 		$15 Hold
667
– – ﹤0.01% 510
2020
Q2 		$11K Hold
667
– – ﹤0.01% 490
2020
Q1 		$9K Hold
667
– – ﹤0.01% 455
2019
Q4 		$14K Buy
+667
New +$16.9K ﹤0.01% 509
2019
Q2 		– Sell
-667
Closed -$26 – 386
2019
Q1 		$26 Buy
+667
New +$29.1K 0.01% 392

Other funds holding VTGN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return

Koshinski Asset Management's VTGN Position: Q4 2021 in Review

Koshinski Asset Management sold out of VistaGen Therapeutics (VTGN) in Q4 2021, closing a stake of 120 shares — an estimated $9.86K sold.

Koshinski Asset Management first reported a position in VTGN in Q1 2019 and held it in 7 quarters. The position peaked at $44K in Q4 2020. 106 funds tracked by Wall St. Rank hold VTGN as of Q4 2021.

  • Koshinski Asset Management reported no remaining VistaGen Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Koshinski Asset Management sold 120 VistaGen Therapeutics shares in Q4 2021, an estimated $9.86K.
  • Koshinski Asset Management first reported a position in VistaGen Therapeutics in Q1 2019 and held it in 7 quarters.
  • Koshinski Asset Management's VistaGen Therapeutics position peaked at $44K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q4 2021.

Based on Koshinski Asset Management's 13F filing for Q4 2021, filed 14 Jan 2022.